Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
153 | Cancer Treatment and Research | journal | 0.325 Q3 | 65 | 23 | 373 | 1510 | 241 | 359 | 0.64 | 65.65 | 23.33 | |
152 | Analytical Cellular Pathology | journal | 0.365 Q3 | 35 | 27 | 25 | 1153 | 27 | 24 | 1.08 | 42.70 | 42.11 | |
151 | Tumori | journal | 0.367 Q3 | 59 | 154 | 524 | 3679 | 474 | 496 | 0.77 | 23.89 | 40.65 | |
150 | International Journal of Cancer Research (discontinued) | journal | 0.383 Q3 | 18 | 88 | 42 | 973 | 54 | 42 | 1.50 | 11.06 | 29.63 | |
149 | Oncology Research and Treatment | journal | 0.405 Q3 | 55 | 141 | 445 | 2898 | 390 | 350 | 0.80 | 20.55 | 32.60 | |
148 | In Vivo | journal | 0.432 | 72 | 136 | 444 | 4068 | 612 | 442 | 1.38 | 29.91 | 35.22 | |
147 | Cancer Biomarkers | journal | 0.439 Q3 | 54 | 80 | 158 | 6869 | 218 | 151 | 1.08 | 85.86 | 41.94 | |
146 | Oncology | journal | 0.490 Q3 | 83 | 306 | 652 | 3678 | 508 | 489 | 0.84 | 12.02 | 31.80 | |
145 | Human Cell | journal | 0.516 Q3 | 44 | 25 | 49 | 665 | 64 | 49 | 1.51 | 26.60 | 35.14 | |
144 | Experimental Oncology | journal | 0.535 Q3 | 48 | 50 | 174 | 1252 | 275 | 162 | 1.54 | 25.04 | 47.22 | |
143 | Brain Tumor Pathology | journal | 0.536 Q3 | 45 | 52 | 51 | 1401 | 92 | 51 | 1.47 | 26.94 | 19.63 | |
142 | Clinical and Translational Oncology | journal | 0.540 Q3 | 61 | 146 | 455 | 5424 | 599 | 405 | 1.17 | 37.15 | 41.22 | |
141 | International Journal of Biological Markers | journal | 0.569 Q3 | 47 | 40 | 111 | 1219 | 184 | 107 | 1.73 | 30.48 | 41.92 | |
140 | Critical Reviews in Oncogenesis | journal | 0.574 Q3 | 57 | 21 | 27 | 1628 | 27 | 19 | 2.00 | 77.52 | 44.44 | |
139 | Cancer Informatics | journal | 0.585 Q3 | 37 | 22 | 90 | 806 | 122 | 86 | 1.16 | 36.64 | 27.50 | |
138 | Current Problems in Cancer | journal | 0.591 Q3 | 47 | 28 | 60 | 1200 | 70 | 39 | 1.16 | 42.86 | 45.00 | |
137 | Journal of Experimental Therapeutics and Oncology | journal | 0.604 Q3 | 40 | 31 | 63 | 973 | 126 | 61 | 1.55 | 31.39 | 38.46 | |
136 | Neoplasma | journal | 0.618 Q3 | 57 | 78 | 251 | 2673 | 446 | 251 | 1.82 | 34.27 | 46.22 | |
135 | Medical Oncology | journal | 0.641 Q3 | 90 | 355 | 404 | 9693 | 648 | 394 | 1.57 | 27.30 | 37.72 | |
134 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.650 Q3 | 68 | 86 | 261 | 3784 | 560 | 251 | 2.15 | 44.00 | 39.08 | |
133 | Oncology Research | journal | 0.654 Q3 | 76 | 33 | 144 | 1308 | 246 | 142 | 1.60 | 39.64 | 33.16 | |
132 | Pathology and Oncology Research | journal | 0.656 Q3 | 61 | 133 | 261 | 4149 | 495 | 260 | 1.73 | 31.20 | 39.04 | |
131 | Technology in Cancer Research and Treatment | journal | 0.669 Q3 | 72 | 64 | 184 | 2148 | 391 | 174 | 2.02 | 33.56 | 24.79 | |
130 | Current Hematologic Malignancy Reports | journal | 0.681 Q3 | 44 | 34 | 90 | 1566 | 149 | 90 | 2.16 | 46.06 | 40.00 | |
129 | Journal of Oral Pathology and Medicine | journal | 0.704 Q3 | 95 | 118 | 345 | 4394 | 865 | 336 | 1.98 | 37.24 | 43.00 | |
128 | Update on Cancer Therapeutics | journal | 0.705 Q3 | 13 | 0 | 18 | 0 | 35 | 16 | 1.33 | 0.00 | 0.00 | |
127 | Anticancer Research | journal | 0.771 Q3 | 136 | 632 | 2019 | 18669 | 4136 | 2014 | 2.08 | 29.54 | 29.86 | |
126 | Cancer Genomics and Proteomics | journal | 0.779 Q3 | 50 | 29 | 95 | 1372 | 197 | 95 | 2.45 | 47.31 | 34.73 | |
125 | Cancer Epidemiology | journal | 0.780 Q3 | 86 | 114 | 268 | 4142 | 617 | 255 | 2.37 | 36.33 | 49.00 | |
124 | Cancer Genetics and Cytogenetics | journal | 0.815 Q3 | 78 | 0 | 639 | 0 | 931 | 524 | 1.38 | 0.00 | 0.00 | |
123 | Infectious Agents and Cancer | journal | 0.825 Q3 | 47 | 36 | 71 | 1328 | 178 | 71 | 2.46 | 36.89 | 47.32 | |
122 | Japanese Journal of Clinical Oncology | journal | 0.855 Q3 | 95 | 241 | 541 | 4807 | 1221 | 502 | 2.02 | 19.95 | 16.21 | |
121 | Mini-Reviews in Medicinal Chemistry | journal | 0.855 | 107 | 108 | 395 | 10227 | 1177 | 393 | 2.84 | 94.69 | 37.46 | |
120 | European Journal of Cancer Prevention | journal | 0.864 Q3 | 88 | 89 | 222 | 3175 | 571 | 220 | 2.40 | 35.67 | 43.08 | |
119 | Oncology Reports | journal | 0.882 Q3 | 115 | 421 | 1290 | 14596 | 2896 | 1290 | 2.19 | 34.67 | 31.25 | |
118 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.890 Q3 | 65 | 124 | 300 | 3566 | 589 | 278 | 1.96 | 28.76 | 37.29 | |
117 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.900 Q3 | 90 | 110 | 347 | 3403 | 824 | 334 | 2.15 | 30.94 | 32.81 | |
116 | Familial Cancer | journal | 0.901 Q3 | 67 | 94 | 222 | 3157 | 406 | 215 | 1.63 | 33.59 | 53.90 | |
115 | Nutrition and Cancer | journal | 0.911 Q3 | 130 | 149 | 341 | 6686 | 1095 | 336 | 3.32 | 44.87 | 47.89 | |
114 | Cancer Cell International | journal | 0.924 Q3 | 80 | 43 | 94 | 2046 | 236 | 93 | 2.27 | 47.58 | 44.84 | |
113 | Tumor Biology | journal | 0.934 Q3 | 101 | 140 | 155 | 4076 | 354 | 153 | 2.27 | 29.11 | 40.10 | |
112 | Breast | journal | 0.943 | 98 | 162 | 351 | 5269 | 794 | 313 | 2.26 | 32.52 | 42.23 | |
111 | International Journal of Hyperthermia | journal | 0.945 Q3 | 98 | 84 | 227 | 3624 | 594 | 209 | 2.25 | 43.14 | 24.92 | |
110 | Gastric Cancer | journal | 0.949 Q3 | 99 | 59 | 134 | 1380 | 297 | 106 | 2.29 | 23.39 | 17.02 | |
109 | Leukemia Research | journal | 0.963 Q3 | 96 | 407 | 1410 | 8649 | 2377 | 968 | 1.60 | 21.25 | 43.95 | |
108 | Targeted Oncology | journal | 0.985 Q2 | 59 | 29 | 98 | 1731 | 266 | 85 | 3.89 | 59.69 | 42.11 | |
107 | Prostate Cancer and Prostatic Diseases | journal | 0.986 Q2 | 78 | 54 | 187 | 1751 | 440 | 174 | 2.54 | 32.43 | 26.21 | |
106 | Anti-Cancer Drugs | journal | 0.991 Q2 | 102 | 136 | 385 | 5427 | 1013 | 379 | 2.71 | 39.90 | 35.12 | |
105 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.997 Q2 | 52 | 33 | 70 | 4134 | 212 | 70 | 3.40 | 125.27 | 44.66 | |
104 | Melanoma Research | journal | 0.998 Q2 | 80 | 73 | 205 | 2650 | 452 | 183 | 2.06 | 36.30 | 43.44 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®